Contact Dermatitis Pipeline Report: Guide Features Descriptive Drug Profiles & Other Developmental Activities

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Contact Dermatitis – Pipeline Review, H1 2018, provides an overview of the Contact Dermatitis (Dermatology) pipeline landscape.

Pune, India – March 29, 2018 /MarketersMedia/ —

Contact dermatitis is a type of skin inflammation that occurs when substances touching skin cause irritation or an allergic reaction. Signs and symptoms of contact dermatitis include red rash or bumps, dry, cracked, red patches, which may resemble a burn and pain or tenderness. There are two types of contact dermatitis; irritant and allergic. Irritant dermatitis, the most common type, is caused by contact with acids, alkaline materials such as soaps and detergents, fabric softeners, solvents, or other chemicals. The reaction usually looks like a burn. Allergic contact dermatitis is an itchy skin condition caused by an allergic reaction to allergen. Treatment includes oral corticosteroids and antihistamines to relieve intense itching.
Report Source: https://www.themarketreports.com/report/contact-dermatitis-pipeline-review-h1-2018
Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Contact Dermatitis (Dermatology).
• The pipeline guide reviews pipeline therapeutics for Contact Dermatitis (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Contact Dermatitis (Dermatology) therapeutics and enlists all their major and minor projects.
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036782
Reasons To Buy
• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Contact Dermatitis (Dermatology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Contact Dermatitis (Dermatology) pipeline depth and focus of Indication therapeutics.
Companies Mentioned
• Brickell Biotech Inc
• Dr. August Wolff GmbH & Co KG Arzneimittel
• NeuroCycle Therapeutics GmbH
• Novartis AG
• Pfizer Inc
• RaQualia Pharma Inc
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036782

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/contact-dermatitis-pipeline-report-guide-features-descriptive-drug-profiles-other-developmental-activities/322591

For more information, please visit https://www.themarketreports.com/report/contact-dermatitis-pipeline-review-h1-2018%20%20

Source: MarketersMedia

Release ID: 322591